Introduction &
The defi nition of Graves ' Orbitopathy (GO) encompasses a series of pathological changes taking place inside and around the orbit, in association with autoimmune thyroid disease ( Burch & Wartofsky, 1993 , Bartalena et al., 2000 , Bartalena et al., 2004 . The natural history of GO commonly recognizes two distinct phases: an initial dynamic phase of " active disease " , characterized by conspicuous lymphocyte and mononuclear cells infi ltration and by fi broblast proliferation ( Wiersinga & Prummel, 2001 , Prabhakar et al., 2003 . In its late phase, the disease progresses into a static " inactive " state, characterized by fi brosis ( Burch & Wartofsky, 1993 
Abstract &
The present study was aimed to investigate optic nerve involvement by computerized perimetry in 40 (29 women, 11 men) consecutive GO patients not showing defi nite dysthyroid optic neuropathy (DON). All patients presenting visual acuity defects, pallor or swelling of the optic nerve, concomitant eye disease, evidence of apical crowding or optic nerve stretching at either MRI or CT imaging were excluded. Normal perimetry occurred in 7 patients (17.5 % ), 5 patients (12.5 % ) had "indeterminate" results and 28 patients (70 % ) presented abnormal perimetry. Particularly, 7 isolated paracentral, 5 pericentral and 16 combined peri and paracentral scotomas were found. On the contrary, 15 / 20 patients in the group without GO had normal perimetry, isolated scotomas were found in 5 cases (1 pericentral and 4 paracentral) and no case of combined scotoma occurred. The difference between the 2 groups was statistically significant ( 2 = 9.17; p = 0.025). Overall, the sensitivity resulted 70 % , the specifi city 75 % and the positive predictive value 84.84 % . In patients with GO, the proportion of visual fi eld alterations was signifi cantly increased for Clinical Activity Score ≥ 3 (p = 0.0005), while no relationship occurred with proptosis degree (p = 0.115). In conclusion, a great proportion of GO patients without clinically evident DON presents visual fi eld defects, mainly related to GO activity. 
Methods

&
Ophtalmological and orthoptic assessment
Eyelid position was established by measuring the lid fi ssure at the midline in primary gaze. Proptosis measurement was performed always by the same observer, using Hertel exophthalmometer. Corneal and conjunctival status was evaluated by slit lamp evaluation. Best corrected visual acuity was expressed as a Snellen fraction and colour vision was tested using Ishihara colour tables. Ocular motility was evaluated with respect to the presence of manifest strabismus; monocular ductions were measured in degrees of excursion from the primary position and both cover test and Hess ' s screen were also performed. The evaluation of optic disc alterations was performed by fundus examination. Tonometry was measured in primary position and in upper and lateral gaze, using Goldman applanation tonometry. Patients were also investigated for the presence of excessive watering, photophobia, grittiness, double vision and blurred vision.
Assessment of disease activity
GO activity was estimated as Clinical Activity Score (CAS) using the EUGOGO atlas ( Dickinson & Perros, 2001 ). Briefl y, one point was added when each of the following items was present: spontaneous pain behind the globe, pain on attempted upgaze, redness of the conjunctiva, redness of the eyelid, chemosis, swelling of the caruncle, and eyelid swelling. CAS score < 3 was considered inactive, ≥ 3 < 5 borderline and >5 active disease.
Computerized visual fi eld examination
Visual fi eld analysis was performed by the Humphrey fi eld analyzer HFA II model 750, using the 30-2 threshold test and evaluated using the software provided by the manufacturer (STATPAC for windows). All patients were previously instructed and experienced automated threshold perimetry examination prior to enter in the study protocol. To be considered reproducible individual fi eld defects had to be confi rmed in at least two separate testing sessions performed within 2 weeks. The results obtained starting from the second visual fi eld examination were taken into consideration for data analysis. In each patient, sensitivity loss at a given location was confi rmed within ± 2 dB. The locations of defects were confi rmed within ± 6 ° . Scotoma was defi ned as at least 2 adjacent points of ≥ 5 decibels sensitivity loss for each point or as 1 or more points of at least 10 decibels sensitivity loss.
Exclusion criteria
All patients presenting any of the following conditions were excluded from the study: 1) previous treatment for GO; visual acuity < 0.67. Snellen fraction; 2) altered colour vision; 3) evidence of keratopathy at slid lamp evaluation; 4) swelling or pallor of the optic disc at fundoscopy; 5) concomitant eye disease that might affect the results of the test (such as severe myopia, astigmatism, cataract, glaucoma, maculopathy); 6) evidence of apical crowding or optic nerve stretching at either MRI or CT imaging.
Statistics &
The comparisons of the frequency distributions were performed using the test or the Fisher exact test, when appropriate. 
Results
& Clinical characteristics of the GO patients
Prevalence of visual fi eld alterations in GO patients and in Graves ' patients without GO
The results of visual fi eld examination in the population under study were compared to a group of Graves ' disease patients without GO, matched for sex and age, with comparable thyroid functional status ( Table 2 ) . Anti-Tg, anti-TPO and anti-TSH receptor (TRAB) antibody profi les are also summarized in Table 2 and were not signifi cantly different between the 2 groups. In the GO group, normal perimetry was present in 7 patients (17.5 % ) only. Five patients (12.5 % ) presented visual fi eld defects at the fi rst ophthalmologic evaluation not confi rmed at further control, were classifi ed as indeterminate and were included in the normal perimetry group for further data analysis. In 28 / 40 cases (70 % ) various types of visual fi eld defects were present. In particular, isolated scotomas occurred in 12 patients (5 pericentral, 7 paracentral) and 16 patients presented combined (pericentral + paracentral) scotomas. On the contrary, 15 / 20 patients in the group without GO had normal perimetry, isolated scotomas were found in 5 cases (1 pericentral and 4 paracentral) occurring in 4 hyperthyroid and in one euthyroid patients. No case of combined scotoma was observed. The difference between the 2 groups was statistically signifi cant ( 2 = 9.17; p = 0.025). By considering the overall data, the sensitivity was 70 % , the specifi city resulted 75 % and the positive predicting value (PPV) 84.84 % .
Frequency of visual fi eld alterations in relation to proptosis
Perimetric abnormalities were observed in 10 / 22 (45.5 % ). patients with proptosis < 20 mm, in 10 / 15 (66.6 % ) subjects with proptosis ≥ 20 < 25 mm and in all 3 cases with proptosis >25 mm ( ᭹ ᭤ Fig. 1 ). The frequency of visual fi eld defects occurring in patients with proptosis >20 mm did not signifi cantly differ from that observed in patients with proptosis < 20 mm (Fisher exact test p = 0.115). ( Henson et al., 2000 ) . In this respect, a high rate of misinterpretation in our series seems unlikely, since we classifi ed as abnormal only the results of the patients whose visual fi eld alterations were confi rmed in 2 different occasions. In addition, if this were the case, one should expect a comparably high frequency of misinterpretation in the control group (i.e. hyperthyroid Graves ' patients without GO). On the contrary, the frequency of visual fi eld defects was markedly low in such patients and signifi cantly reduced as compared to the GO series. Thus, the presence of perimetric alterations was rather specifi c (75 % specifi city) for GO patients, as also indicated by a PPV of 84.84 % . One alternative hypothesis could be that the observed perimetric defects would refl ect subclinical involvement of the optic nerve, particularly in those patients (11 / 40) who showed a mild reduction of the visual acuity. However, in the absence of acquired altered color vision or reduced acuity, this alternative seems highly unlikely. On the other hand, the possible mechanisms leading to a subclinical optic nerve involvement in our series of GO patients cannot be easily explained. In fact, a direct mechanical effect in terms of optic nerve compression should be ruled out, since all patients with TC or MNR evidence of apical crowding or optic nerve stretching were excluded from the study. In addition, no signifi cant relationship was observed with proptosis, nor with GO severity or intraocular pressure (data not shown). On the contrary, visual fi eld defects were signifi cantly associated to GO activity. In fact, the major fi nding emerging from our study relates to the observation that patients with CAS ≥ 3 were more likely to present perimetric alterations as compared to patients with CAS < 3. In other words, the infl ammation would have a more detrimental effect on the visual fi eld in patients with more active GO. In this perspective, it cannot be excluded that an involvement of the optic nerve in the infl ammatory process taking place inside the orbit would be responsible for the perimetric alterations in GO patients. Possibly, TRAB could be involved in this process, since it has been shown that these auto-antibodies may play an important role in triggering and maintaining the autoimmune process in the orbit ( Eckstein et al., 2006 ) . Based on our data, showing no signifi cant difference in TRAB levels between the groups of Graves ' patients with and without GO, a role of TRAB in determining subclinical optic nerve involvement seems unlikely. In addition, when TRAB results were analyzed according to perimetric alterations among the various subgroups, no correlation between TRAB values and the presence of visual fi eld defects was observed (data not shown). In this respect, however, it should be emphasized that our protocol was not originally designed to address this question. Therefore, we cannot exclude that other factors (i.e. the reference range for TRAB positivity used in our laboratory, the great proportion of patients with positive TRAB in both groups, the dispersion over a wide range of individual TRAB-positive values) could have infl uenced to some extent this kind of data analysis. Since visual fi eld defects were present in approximately half the series of patients with no other evidence of optic nerve damage, other mechanisms such as the alteration of the tear fi lm profi le known to occur in GO patients ( Khurana, 1992 ) as well as irregular refractive errors due to lid position and / or excessive tearing induced by increased corneal exposure could eventually play a role in determining the visual fi eld defects in GO patients.
Frequency of visual fi eld alterations in relation to CAS
In conclusion, patients with active GO present a remarkably higher prevalence of visual fi eld defects as compared to Graves ' disease patients without GO. Further studies will clarify the mechanisms leading to such abnormalities and their exact clinical relevance.
